Clinical trials recruiting in Valence, France

Phase breakdown

Conditions recruiting in Valence, France

Recruiting trials in Valence, France

• A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
  NCT06430801 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female)
• COsegregation of VARiants in Panel of Genes
  NCT01689584 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib
  NCT07237256 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Female
• DESTINY Breast Respond HER2-(Ultra)Low Europe
  NCT05945732 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease
  NCT07292012 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Predictive Factor of Response to Anti-PD-1
  NCT05856565 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
  NCT06112314 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Impact of a Physical Activity Intervention With Motivational Support From Peers for Prostate Cancer Patients
  NCT05739565 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male
• Neoadjuvant Immunotherapy of Operable Metastatic Melanoma in Real Life (GCC)
  NCT06586593 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
  NCT05232916 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: All (male and female)
• Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA
  NCT06207981 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Prospective National Cohort Evaluating Prognostic Factors for Efficacy of Fruquintinib Treatment in Patients With Metastatic Colorectal Cancer
  NCT07124858 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• REBECCA Real-world Early BrEast CanCer mAnagement
  NCT06856343 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated
  NCT06908993 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
  NCT07290803 · Phase: Not specified · Ages: 12 Years and older · Sex: All (male and female)
• Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer
  NCT03819101 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male

Common questions

How many clinical trials are recruiting in Valence, France?

16 recruiting trials have at least one study site in Valence, France.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.